<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548742</url>
  </required_header>
  <id_info>
    <org_study_id>SPLE-012-11S</org_study_id>
    <secondary_id>CX-11-012</secondary_id>
    <nct_id>NCT01548742</nct_id>
  </id_info>
  <brief_title>Meditation Interventions for Treatment of PTSD in Veterans</brief_title>
  <acronym>VMP</acronym>
  <official_title>Meditation Interventions for Treatment of PTSD in Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder which results in&#xD;
      serious impairments in interpersonal, occupational and social functioning. Effective&#xD;
      treatments are available for PTSD but they do not work for everyone. Alternative treatments&#xD;
      are needed to help those veterans not helped by currently available treatments. Mindfulness&#xD;
      Based Stress Reduction (MBSR) is a group based treatment focused on mindfulness meditation.&#xD;
      MBSR has been found to be effective in helping people with problems with pain and anxiety.&#xD;
      MBSR has not yet been studied in veterans with PTSD. The proposed study will compare MBSR&#xD;
      with a standard psychotherapy treatment in veterans with PTSD. This research is relevant to&#xD;
      Veterans' health because of the need to develop alternative treatments for veterans with PTSD&#xD;
      who have not responded to currently available treatments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder associated with&#xD;
      high rates of chronicity, poor quality of life, and severe impairments in interpersonal,&#xD;
      occupational, and social functioning. While evidence-based psychotherapies for treatment of&#xD;
      PTSD have been developed and disseminated within the VA system, no treatment has shown&#xD;
      universal effectiveness and there have been great concerns about attenuated treatment&#xD;
      response and elevated treatment drop out in veteran populations. The evaluation of&#xD;
      alternative treatment modalities for veterans with PTSD is therefore an important priority.&#xD;
      The Minneapolis VA Health Care System (MVAHCS) has taught Mindfulness Based Stress Reduction&#xD;
      (MBSR), a group-based intervention focused on mindfulness meditation, to veteran clinical&#xD;
      populations since 2001, and pilot data from veterans diagnosed with PTSD is promising.&#xD;
      Despite support for the application of MBSR to other mental health and physical problems,&#xD;
      MBSR has not been systematically evaluated as a treatment for PTSD. Moreover, the existing&#xD;
      literature on MBSR is limited by methodological weaknesses. If shown to be efficacious&#xD;
      through scientifically sound trials, MSBR may offer an effective, acceptable, and tolerable&#xD;
      intervention for veterans suffering PTSD who are unable to engage in or complete traditional&#xD;
      exposure-based therapies. The primary goal of this proposal is to conduct a methodologically&#xD;
      rigorous randomized controlled trial (RCT) of MBSR in treating PTSD among veterans, examining&#xD;
      both symptom outcomes and subsequent health services utilization. Given our compelling pilot&#xD;
      data, we propose initial steps to evaluate putative mechanisms of change (self-report and&#xD;
      electrophysiology markers, i.e., EEG) through which MBSR may relate to PTSD symptom&#xD;
      improvements, and to examine the acceptability of MBSR to the veteran population.&#xD;
&#xD;
      The MVAHCS and the assembled team combines expertise in PTSD treatment and research, clinical&#xD;
      trials, and neuroscience, with clinical expertise in MBSR and compelling pilot data to&#xD;
      support the feasibility and scope of the current project. The efficacy of MBSR will be&#xD;
      examined relative to present-centered group therapy (PCGT), a non-specific therapeutic&#xD;
      comparison group. Veterans diagnosed with PTSD will be randomized to MBSR or PCGT for 9&#xD;
      weeks. Each intervention will be delivered in group format following manualization by trained&#xD;
      clinicians receiving expert supervision. Treatment integrity will be independently monitored.&#xD;
      Assessment of clinical outcomes post-treatment and 2 months follow-up will be independently&#xD;
      evaluated. Putative mechanisms of mindfulness meditation will be assessed using self-report&#xD;
      and electrophysiology markers. We have the following aims:&#xD;
&#xD;
      Primary Aim 1: To evaluate the efficacy of MBSR as a treatment for PTSD in veterans compared&#xD;
      to PCGT over 9-weeks of treatment and 2-month follow-up.&#xD;
&#xD;
      Secondary Aim 1: To identify potential treatment-based predictors of PTSD outcomes.&#xD;
&#xD;
      Secondary Aim 2: To identify differences in subsequent VA health services utilization among&#xD;
      veterans across treatment conditions.&#xD;
&#xD;
      Exploratory Aims:&#xD;
&#xD;
        1. To evaluate rates of drop-out, compliance, and consumer satisfaction with MBSR.&#xD;
&#xD;
        2. To evaluate acceptability and outcomes of treatment with veterans with mild traumatic&#xD;
           brain injuries.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up</measure>
    <time_frame>Baseline, Weeks 3, 6, 9 and 17</time_frame>
    <description>The PCL is a valid and reliable measure of PTSD symptoms. Score range from 17-85; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the PCL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up</measure>
    <time_frame>Baseline, Weeks 9 and 17</time_frame>
    <description>The CAPS is a valid and reliable measure of PTSD symptom severity. Score range from 0-136; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the CAPS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up</measure>
    <time_frame>Baseline, Weeks 9 and 17</time_frame>
    <description>The PHQ-9 is a valid and reliable measure of depression symptom severity. Score range from 0-27; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 5 or more points on the PHQ-9.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinically Significant Improvement in Self-reported PTSD Symptoms as Measured by the PCL</measure>
    <time_frame>Weeks 9 and 17</time_frame>
    <description>% of participants with clinically significant improvement in self-reported PTSD symptoms defined as a reduction of 10 points or more on the PCL.</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinically Significant Improvement in Clinician Administered PTSD Scale (CAPS)</measure>
    <time_frame>Weeks 9 and 17</time_frame>
    <description>% of participants with clinically significant improvement in interviewer-rated PTSD symptom severity defined as a reduction of 10 points or more on the CAPS.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <arm_group>
    <arm_group_label>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness-Based Stress Reduction (MBSR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Present-Centered Group Therapy (PCGT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Present-Centered Group Therapy (PCGT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Stress Reduction (MBSR)</intervention_name>
    <description>Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
    <arm_group_label>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</arm_group_label>
    <other_name>MBSR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Present-Centered Group Therapy (PCGT)</intervention_name>
    <description>Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
    <arm_group_label>Arm 2: Present-Centered Group Therapy (PCGT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female veterans who are 18 years or older.&#xD;
&#xD;
          -  Must meet current DSM-IV criteria for PTSD based on the Clinician Administered PTSD&#xD;
             Scale (CAPS) or have a PTSD Checklist (PCL) score between 40 and 60.&#xD;
&#xD;
          -  If taking psychoactive medications, must be on a stable regime for 8 weeks or more.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current suicidal or homicidal ideation with intent and/or plan that, in the judgment&#xD;
             of the investigator, should be the focus of treatment.&#xD;
&#xD;
          -  Current substance dependence (not in sustained remission), current or recent (within&#xD;
             past 6 months) manic episode, or active psychosis. To be eligible, if veteran has&#xD;
             current diagnosis of bipolar disorder, there is evidence that illness has been stable&#xD;
             for at least 6 months on medication. Has unstable or serious medical illness,&#xD;
             including history of stroke, seizure disorder, or unstable cardiac disease that would&#xD;
             interfere with participation in treatment.&#xD;
&#xD;
          -  Severe cognitive impairment or moderate/severe traumatic brain injury.&#xD;
&#xD;
          -  Unable to comprehend or communicate in English.&#xD;
&#xD;
          -  Unwilling to accept random assignment or unwilling to refrain from participating in&#xD;
             other active forms of psychotherapy during 8-week treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelvin Lim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis VA Health Care System, Minneapolis, MN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>March 5, 2012</study_first_submitted>
  <study_first_submitted_qc>March 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <results_first_submitted>September 29, 2015</results_first_submitted>
  <results_first_submitted_qc>November 4, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 10, 2015</results_first_posted>
  <last_update_submitted>November 4, 2015</last_update_submitted>
  <last_update_submitted_qc>November 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Meditation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited through flyers posted in targeted clinics and clinical referrals at the Minneapolis VA Medical Center.</recruitment_details>
      <pre_assignment_details>Participants completed a 5-hour eligibility and baseline assessment that included a structured clinical interview and self-report measures. Randomization occurred for those meeting study inclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
          <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
          <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
          <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
          <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
            <count group_id="B2" value="58"/>
            <count group_id="B3" value="116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.6" spread="10.4"/>
                    <measurement group_id="B2" value="59.4" spread="9.2"/>
                    <measurement group_id="B3" value="58.5" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mixed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Service Era</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>OEF/OIF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gulf War</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vietnam War</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lifetime trauma exposure</title>
          <units>No. of events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.9" spread="3.3"/>
                    <measurement group_id="B2" value="7.5" spread="3.0"/>
                    <measurement group_id="B3" value="7.7" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lifetime trauma exposure event type</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Combat exposure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sexual trauma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical assault</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Disaster exposure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious accident</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Life-threatening illness or injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other traumatic event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PTSD diagnosis</title>
          <description>Full PTSD criteria defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). Subthreshold PTSD defined as endorsement of DSM-IV criterion A1 and at least 1 symptom each from criteria B, C, and D with significant impairment.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Full PTSD criteria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subthreshold PTSD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbid mood disorder</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Taking psychotropic medication</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total number of psychotherapy mental health visits</title>
          <units>sessions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.2" spread="28.3"/>
                    <measurement group_id="B2" value="14.6" spread="29.2"/>
                    <measurement group_id="B3" value="13.9" spread="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of previous mental health care</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.0" spread="53.3"/>
                    <measurement group_id="B2" value="63.9" spread="45.2"/>
                    <measurement group_id="B3" value="66.5" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants receiving 8 or more therapy sessions in PTSD or mental health clinics</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up</title>
        <description>The PCL is a valid and reliable measure of PTSD symptoms. Score range from 17-85; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the PCL.</description>
        <time_frame>Baseline, Weeks 3, 6, 9 and 17</time_frame>
        <population>Intent to treat population (all participants randomized to treatment).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
            <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
            <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
          </group>
        </group_list>
        <measure>
          <title>PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up</title>
          <description>The PCL is a valid and reliable measure of PTSD symptoms. Score range from 17-85; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the PCL.</description>
          <population>Intent to treat population (all participants randomized to treatment).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline PCL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.6" lower_limit="60.6" upper_limit="66.7"/>
                    <measurement group_id="O2" value="58.8" lower_limit="55.7" upper_limit="61.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 PCL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.9" lower_limit="60.8" upper_limit="67.0"/>
                    <measurement group_id="O2" value="61.7" lower_limit="58.6" upper_limit="64.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wee 6 PCL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.3" lower_limit="58.1" upper_limit="64.4"/>
                    <measurement group_id="O2" value="60.7" lower_limit="57.6" upper_limit="63.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 9 PCL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.7" lower_limit="52.6" upper_limit="58.9"/>
                    <measurement group_id="O2" value="55.8" lower_limit="52.7" upper_limit="58.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 17 PCL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.4" lower_limit="51.2" upper_limit="57.6"/>
                    <measurement group_id="O2" value="56.0" lower_limit="52.9" upper_limit="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Clinically Significant Improvement in Self-reported PTSD Symptoms as Measured by the PCL</title>
        <description>% of participants with clinically significant improvement in self-reported PTSD symptoms defined as a reduction of 10 points or more on the PCL.</description>
        <time_frame>Weeks 9 and 17</time_frame>
        <population>Intent to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Mindfulness Based Stress Reduction (MBSR)</title>
            <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Present Centered Group Therapy (PCGT)</title>
            <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinically Significant Improvement in Self-reported PTSD Symptoms as Measured by the PCL</title>
          <description>% of participants with clinically significant improvement in self-reported PTSD symptoms defined as a reduction of 10 points or more on the PCL.</description>
          <population>Intent to treat analysis</population>
          <units>percentage clinical responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>% responders, Week 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.5" lower_limit="24" upper_limit="49"/>
                    <measurement group_id="O2" value="22.8" lower_limit="10.9" upper_limit="34.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% responders, Week 17</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.9" lower_limit="35.1" upper_limit="62.8"/>
                    <measurement group_id="O2" value="28.1" lower_limit="15.5" upper_limit="40.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up</title>
        <description>The CAPS is a valid and reliable measure of PTSD symptom severity. Score range from 0-136; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the CAPS.</description>
        <time_frame>Baseline, Weeks 9 and 17</time_frame>
        <population>Intent to treat population (all participants randomized to treatment).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
            <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
            <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
          </group>
        </group_list>
        <measure>
          <title>PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up</title>
          <description>The CAPS is a valid and reliable measure of PTSD symptom severity. Score range from 0-136; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the CAPS.</description>
          <population>Intent to treat population (all participants randomized to treatment).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline CAPS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.9" lower_limit="65.0" upper_limit="74.8"/>
                    <measurement group_id="O2" value="62.5" lower_limit="57.6" upper_limit="67.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 9 CAPS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.3" lower_limit="51.0" upper_limit="61.5"/>
                    <measurement group_id="O2" value="51.7" lower_limit="46.5" upper_limit="56.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 17 CAPS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.8" lower_limit="44.3" upper_limit="55.3"/>
                    <measurement group_id="O2" value="50.6" lower_limit="45.4" upper_limit="55.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up</title>
        <description>The PHQ-9 is a valid and reliable measure of depression symptom severity. Score range from 0-27; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 5 or more points on the PHQ-9.</description>
        <time_frame>Baseline, Weeks 9 and 17</time_frame>
        <population>Intent to treat population (all participants randomized to treatment).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
            <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
            <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up</title>
          <description>The PHQ-9 is a valid and reliable measure of depression symptom severity. Score range from 0-27; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 5 or more points on the PHQ-9.</description>
          <population>Intent to treat population (all participants randomized to treatment).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline PHQ-9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" lower_limit="13.9" upper_limit="17.0"/>
                    <measurement group_id="O2" value="14.6" lower_limit="13.1" upper_limit="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 9 PHQ-9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.6" lower_limit="12.0" upper_limit="15.1"/>
                    <measurement group_id="O2" value="13.9" lower_limit="12.3" upper_limit="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 17 PHQ-9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="11.7" upper_limit="15.0"/>
                    <measurement group_id="O2" value="13.8" lower_limit="12.2" upper_limit="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Clinically Significant Improvement in Clinician Administered PTSD Scale (CAPS)</title>
        <description>% of participants with clinically significant improvement in interviewer-rated PTSD symptom severity defined as a reduction of 10 points or more on the CAPS.</description>
        <time_frame>Weeks 9 and 17</time_frame>
        <population>Intent to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Mindfulness Based Stress Reduction (MBSR)</title>
            <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Present Centered Group Therapy (PCGT)</title>
            <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinically Significant Improvement in Clinician Administered PTSD Scale (CAPS)</title>
          <description>% of participants with clinically significant improvement in interviewer-rated PTSD symptom severity defined as a reduction of 10 points or more on the CAPS.</description>
          <population>Intent to treat analysis</population>
          <units>percentage clinical responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>% responders, Week 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.5" lower_limit="49.8" upper_limit="77.1"/>
                    <measurement group_id="O2" value="49.1" lower_limit="36.1" upper_limit="62.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% responders, Week 17</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="52.1" upper_limit="81.2"/>
                    <measurement group_id="O2" value="54.5" lower_limit="41.4" upper_limit="67.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: Mindfulness-Based Stress Reduction (MBSR)</title>
          <description>Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Present-Centered Group Therapy (PCGT)</title>
          <description>Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Crushed by falling tree</sub_title>
                <description>Survived with multiple physical injuries</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Suicide Attempt or worsening of symptoms</sub_title>
                <description>Resulted in inpatient hospitalization.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Initial analyses did not account for clustering effects. However, when we re-analyzed data using a multilevel model including a random effect for therapy group, we found that the results were essentially unchanged.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kelvin O. Lim, MD (Principal Investigator)</name_or_title>
      <organization>Minneapolis VA Medical Center</organization>
      <phone>612-467-3323</phone>
      <email>kolim@umn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

